Contribution of FDG-PET on staging and management of NSCLC planned for concomitant chemoradiotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 664s Year: 2007
Concurrent WBBS and FDG-PET and primary staging of NSCLC, a retrospective analysis Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities Year: 2009
Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC. Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020
Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007
Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0. Source: International Congress 2019 – General thoracic surgery Year: 2019
Prospective evaluation of repeat integrated PET/CT scan after induction therapy for stage IIIA-N2 lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=186 Year: 2006
Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer Year: 2007
Is invasive staging necessary for NSCLC cases with no mediastinal N2 in PET/CT and thorax CT imaging? Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008
The effect of PET-CT before surgery in primary lung cancer, a retrospective quality assurance analysis Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010
No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team Source: Eur Respir J 2009; 33: 941-942 Year: 2009
Staging and restaging in the era of multimodality treatment Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006
Comparison of integrated PET-CT remediastinoscopy to restage IIIA-N2 NSCLC after induction chemotherapy Source: ISSN=ISSN 1810-6838, ISBN=, page=289 Year: 2007
Study to assess the utility of head CT in the staging of lung cancer in the post-PET era Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
The comparison of the findings of preoperative PET-CT and surgical pathology in patients with non-small cell lung cancer those with and without induction therapy Source: Annual Congress 2011 - General thoracic surgery II Year: 2011
Does routine use of EBUS-TBNA and EUS-FNA improve the accuracy of staging of non small cell lung cancer patients – A national tumor registry based study Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011
Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first? Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014
Endosonography followed by surgical staging vs. surgical staging alone for lung cancer Source: Annual Congress 2010 - Waves and needles: ultrasound guided diagnostic Year: 2010
Correlation between clinical and pathological staging in resectable NSCLC - analysis on 360 surgical cases Source: Eur Respir J 2001; 18: Suppl. 33, 131s Year: 2001
Combining bronchoscopy and PET for assessment and staging of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 678s Year: 2005